For instance, EPHB2 is highly expressed in hepatocellular carcinoma, lung adenocarcinoma, gastric cancer, and CRC (59, 63–65) but lowly expressed in esophageal cancer and squamous cell carcinoma of the skin (66, 67). Here, EPHB2 is linked to esophageal cancer.